METHOD TO IMPROVE THE IMMUNOGENICITY OF VACCINE ANTIGENS BY MODIFICATION OF CLEAVAGE SITES IN HIV-1 GP 120

摘要

Disclosed are novel methods for altering the immunogenicity of vaccine antigens by mutation of cleavage sites recognized by proteases involved in antigen presentation and processing. Also disclosed are therapeutic compositions, vaccines and methods for treating or preventing HIV and other viral diseases.